MolNFT v1 · #58875 · protein
Human pim-1 complexed with a benzoisoxazole inhibitor VX1
3BGP · Proto-oncogene SERINE/THREONINE-protein kinase pim-1: “Human pim-1 complexed with a benzoisoxazole inhibitor VX1”. X-ray diffraction, 1 ligand (VX1), 2 pockets (best druggability 0.65). MolNFT v1 #58875 on GenesisL1: 3D structure…
- PDB
- 3BGP
- Type
- protein
- Length
- 273 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Proto-oncogene SERINE/THREONINE-protein kinase pim-1
- EC
- 2.7.11.1
- UniProt
- P11309
- Ligands
- VX1
- Pockets
- 2 · best druggability 0.65
Structure
x-ray diffraction · 1 distinct chain · 35% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Proto-oncogene SERINE/THREONINE-protein kinase pim-1 (EC 2.7.11.1) | protein | 273 | 35% helix, 22% strand | P11309 |
Ligands and binding sites
- VX1 · 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 252 | 0.65 | 0.82 | 28 | VX1 |
| 2 | 126 | 0.52 | 0.81 | 22 | empty |
Modifications
Observed in the structure: 1 modified (phosphorylation).
Compared structures
- 3BGP · Human Pim-1 complexed with a benzoisoxazole inhibitor VX1 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P11309
- Elsewhere: RCSB PDB 3BGP · PDBe 3BGP · UniProt P11309
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.